James Lousararian

Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA.

BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts.

ThermoRetec Corp. provides environmental services in the United states. The company was founded by Jeffrey L. Powell and is headquartered in Concord, MA.

Primo Medical Group, Inc. designs and manufactures medical devices and precision machined components. It offers outsourcing solutions to the medical device market, including OEM product distribution services, engineering services, precision component production and finished goods assembly, refurbishment of medical devices, reusable surgical kit management and complete supply chain management. The company was founded in 1953 by Primo Tallarida and is headquartered in Stoughton, MA.

AngioLink Corp. operated as a medical device company that has developed a four-pronged vascular stapling system, the EVS vascular closure system. It's EVS (expanding vascular stapling) vascular closure system, is engineered to close the femoral artery access site after vascular procedures, such as diagnostic angiography, balloon angioplasty and stenting. The company was headquartered in Taunton, MA.

Point Judith Management Co LLC (Point Judith Capital Partner) is a venture capital firm founded in 2001 by David Martirano and Gina Raimondo. The firm is headquartered in Boston, Massachusetts.